DaxibotulinumtoxinA-Ianm

DaxibotulinumtoxinA-Ianm

DaxibotulinumtoxinA is a medication belonging to the neurotoxin class and is utilized to manage and treat moderate-to-severe glabellar lines associated with corrugator or procerus muscle activity in adult patients. This activity provides an overview of the indications, contraindications, and pharmacology for daxibotulinumtoxinA as an agent in the cosmetic management of rhytides. This activity reviews the adverse event profile, off-label uses, dosing, monitoring recommendations, and relevant interactions of this medication to enhance the competence of interprofessional healthcare team members when caring for patients with glabellar lines.

  • Provider:StatPearls, LLC
  • Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/156491
  • Start Date: 2023-09-01 05:00:00
  • End Date: 2023-09-01 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
  • MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
    ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
    ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
    ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Variable
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: All Practice Areas (e.g. ethics), Facial Plastic & Reconstructive Surgery, General Surgery
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.